Picture of Ajanta Pharma logo

AJANTPHARM — Ajanta Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Ajanta Pharma Says Formulation Facility At Dahej Inspected By US FDA

Sept 12 (Reuters) - Ajanta Pharma Ltd  AJPH.NS :
    * FORMULATION FACILITY AT DAHEJ WAS INSPECTED BY US FDA
    * AT END OF FDA INSPECTION, FORM 483 WAS ISSUED WITH 2
PROCEDURAL
OBSERVATIONS

Source text for Eikon:  ID:nBSEY62Px 
Further company coverage:  AJPH.NS 

 ((Reutersbriefs@thomsonreuters.com;))

Recent news on Ajanta Pharma

See all news